PHARMTECH & INGREDIENTS 2021: PRESS-RELEASE
The number of exhibitors at Pharmtech & Ingredients 2021 has doubled
The 23rd International exhibition of equipment, raw materials and technologies for pharmaceutical production, Pharmtech & Ingredients, will take place on 23-26 November 2021, at Crocus Expo.
Today, during the ongoing crisis, when the largest pharmaceutical companies and research laboratories are focused on combating the epidemic, the importance of supplying the pharmaceutical industry with advanced equipment and raw materials comes to the fore. Communication becomes a priority for the industry. Pharmtech & Ingredients has been a unique place for important meetings and key decisions for 23 years. The opinion of the industry’s business community is essential for understanding the challenges and finding the solutions.
More than 300 exhibitors from 25 countries will showcase equipment, raw materials, and technologies for the pharmaceutical industry at Pharmtech & Ingredients 2021. Among the exhibitors, there will be leading world and Russian companies: IMA (Italy), Merck (Germany), Marchesini Group (Italy), BASF (Germany), Antares Vision, Sartorius (Germany), ECI PACKAGING (USA), Sinopharmtech (China), Mikhail Kurako (Russia), Tofflon (China), Rolstec (Russia), OMAG (Italy), Pharma Union (Russia), Catrosa (Spain), IMCoPharma (Czech Republic), Active Component (Russia), PharmVILAR (Russia), Rettenmaier (Germany), Artlife-Techno (Russia), Gerresheimer (Germany), and others.
The Swiss pavilion will showcase the latest developments in the production and packaging of medicines from leading Swiss companies. This year Switzerland will present a wide range of measurement solutions such as microfluidic devices, aseptic machines, and packaging materials. Five manufacturers will be exhibiting at one stand: Hamilton Bonaduz, PEC Project Engineering + Consulting AG, Rommelag, Techno Plastic Products AG and Wingflow. This year Switzerland is taking part in Pharmtech & Ingredients for the sixth time.
Germany will take part in the Pharmtech & Ingredients exhibition with a collective stand for the 12th time, and this year, 25 German companies will showcase their products and services at the German Pavilion. For 12 years of cooperation, from the first year of participation in 2009, 98 exhibitor companies have started their business in Russia.
More than 50 companies will exhibit at Pharmtech & Ingredients for the first time. Among them: Engineering Technologies (Russia, pharmaceutical equipment), CAPSOIL (Israel, raw materials, and ingredients), CHARLES ISCHI (Switzerland, laboratory equipment), VELUDERM LAB (Russia, technologies for cosmetic production), INTRADE (Russia, packaging materials), BIOPAX (Russia, ingredients), Minskintercaps (Belarus, contract manufacturing), Contipro (Czech Republic, ingredients), Biogrowing (China, ingredients), and others.
DM TECHNOMARK, taking part in the exhibition for the first time, will present solutions for labeling, serialization, and aggregation. This Russian company is a software developer and manufacturer of automation labeling and aggregation processes in wholesale warehouses. At the exhibition, the company will present a set of equipment for performing all operations required by the national labeling system, including flow-type aggregation lines with a built-in label application module and tables for aggregation by layer-by-layer scanning.
UNITESS will present its own product UNITESS AMBIENT — a system for monitoring the conditions of production, storage, and transportation of medicines. The system is designed for metrology laboratories and pharmaceutical companies. More than 60% of pharmaceutical companies and distributors in the Republic of Belarus chose UNITESS AMBIENT to confirm their compliance with GMP and GDP requirements.
The Israeli company Capsoil Technologies will take part in Pharmtech & Ingredients for the first time in the “Ingredients” section, and it will present its own oil-based raw material processing technology to the Russian market.
Marchesini Group (Italy) decided to show its flagship — the MA 400 secondary packaging machine, a convenient modernized continuous horizontal cartoning machine with improved ergonomics. The new machine represents the best solution for high-speed packaging of all types of products for the pharmaceutical and cosmetic markets. The model was developed for packaging products in vials.
The German company Sartorius will showcase solutions for biopharmaceuticals — from research to production. Visitors will be able to learn about new products and trusted solutions for the development and production of biological products in the company’s portfolio.
Representatives of the largest pharmaceutical manufacturers in Russia will visit the exhibition: Skopinpharm, Valenta Pharm, BIOCAD, GENERIUM, Pharmasyntez, Canonpharma production, Pharmstandard, OZON, WERTEKS, Sotex PharmFirm, Sintez, Fort, LLC Skopinpharm, Grotex, PETROVAX PHARM, Renewal, NANOLEK, GEROPHARM, Veropharm, Polysan, Nizhpharm, Akrikhin, Gedeon Richter-Rus, KRKA-RUS, Berlin Pharma, Bayer, STADA, Evalar.
This year, the business programme will be focused on the main tasks and prospects for the market development. What problems the industry has faced in the current year? What steps have been taken and what should be done by business and the state?
The business programme will start on November 23 with the plenary session “Availability of medicines for the national health care system: balance of interests of the participants”. During the discussion, representatives of government agencies, national medical research centers, leading industry associations and pharmaceutical companies will talk about one of the three main directions of the “Pharma-2030” strategy and answer an important question — is it possible in the current economic environment to make decisions in the healthcare system that would satisfy the government, pharmaceutical manufacturers, and patients. Co-organizer — GxP News.
On the same day, a round table “API: to be produced or imported” will take place. The COVID-19 pandemic led to necessity to create a full-fledged production of APIs in Russia, but this task cannot be accomplished without a full-scale government support. Is it easy to restore domestic production of pharmaceutical substances and how long will it take? Is it necessary to restore the system exactly as it was? Will pharmaceutical companies continue to buy raw materials abroad? Together with the experts, we will try to solve the problem. The partner of the round table is Reatorg.
The trend towards environmental and industrial safety is actively supported at the exhibition. At the round table “Changing regulatory rules for pharmaceutical waste” the speakers will try to track changes in regulation for such a wide range of areas as production waste, MSW, waste from manufactured and sold goods, medical and biological waste.
On November 24, the round table “Vaccine production in the context of the SARS-CoV-19 pandemic: challenges, scaling, new solutions” will be held to discuss the impact of the widespread use of bioengineered vaccines against new coronavirus infection on the biopharmaceutical market, as well as reorientation and scaling of production facilities to produce COVID-19 vaccine. The partner of the event is Thermo Fisher Scientific.
The 16th International Specialized Forum “Pharmtechprom” will take place on November 24 and 25. This year, the event, a traditional platform for the presentation of the latest technologies in pharmaceutical production, will include four sessions. Companies like Bioiberica, IMCD, Croda, Hosokawa, Asahi Kasei, DIOSNA, Gerresheimer, Bruker, GEA, Marchesini Group Rus will present their latest developments.
In 2021, Pharmtech & Ingredients will be supported by the Ministry of Health of the Russian Federation, the Association of Russian Pharmaceutical Manufacturers, the Union of Professional Pharmaceutical Organizations, and the Association of Medicines Manufacturers of the Republic of Armenia.
Health & Safety
In 2021 Pharmtech & Ingredients has been declared a “COVID-free” exhibition. A “COVID -free” exhibition is an exhibition at which site the “Recommendations for the implementation of measures to prevent the spread of the new coronavirus infection (COVID-19) during congress and exhibition activities” (approved by the Head of Federal Service for Supervision of Consumer Rights Protection and Human Welfare on 26 June 2020) are fully observed.
In accordance with the requirements of Rospotrebnadzor, there will be body temperature screening, as well as check of medical masks and gloves availability. Only the organiser’s employees with the COVID status “vaccinated”, “recovered”, or “negative PCR test”, confirmed by a QR code, will be allowed to work on site.
At the entrance to the exhibition site, all visitors, exhibitors, partners, and mass media representatives will be checked for the presence of a QR code confirming the status of “vaccinated”, “recovered” or “negative PCR test”. Be ready to present your ID or passport to verify your QR code.
- Visitor registration partner — Glatt
- Partner of electronic registration — Harke Rus
- General media partner — GxP News
- Industry media partner — Farmatsevticheskiy vestnik